Lin Yue

436 total citations
21 papers, 296 citations indexed

About

Lin Yue is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Lin Yue has authored 21 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Lin Yue's work include Metabolism, Diabetes, and Cancer (7 papers), Diabetes Treatment and Management (6 papers) and Diet, Metabolism, and Disease (4 papers). Lin Yue is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Diabetes Treatment and Management (6 papers) and Diet, Metabolism, and Disease (4 papers). Lin Yue collaborates with scholars based in China. Lin Yue's co-authors include Xiaoyu Pan, Shuchun Chen, Xing Chen, Zelin Li, Shuchun Chen, Xiaoyi Chen, Xiaoyi Chen, Lin Yang, Xueqing Zhang and Lin Yang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Pharmacology and Molecular and Cellular Biochemistry.

In The Last Decade

Lin Yue

21 papers receiving 294 citations

Peers

Lin Yue

EDM

EPIDE

PHYSI

SURGE

Panwei Mu China

Shuo Pan China

Elizabeth Tatro United States

Mingfeng Cao China

M. Furkan Burak United States

Veronica Manicardi Italy

Aowen Zhuang Australia

Hajnalka Lőrincz Hungary

Shuangtong Yan China

Ting Fang China

Panwei Mu China

Lin Yue

177 ×1.2

165 ×1.4

EDM

78 ×0.9

EPIDE

71 ×1.0

PHYSI

69 ×1.3

SURGE

Citations per year, relative to Lin Yue Lin Yue (= 1×) peers Panwei Mu

Countries citing papers authored by Lin Yue

Since Specialization

Citations

This map shows the geographic impact of Lin Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Yue more than expected).

Fields of papers citing papers by Lin Yue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Yue. The network helps show where Lin Yue may publish in the future.

Co-authorship network of co-authors of Lin Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Yue. A scholar is included among the top collaborators of Lin Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Yue. Lin Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yue, Lin, et al.. (2024). Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism. Open Medicine. 19(1). 20241012–20241012. 2 indexed citations

Pan, Xiaoyu, et al.. (2024). Epidemiological Characterisation of Chronic Diseases Among Civil Servants in Hebei Province, China: A Cross-Sectional Real-World Study of Approximately 50,000 Adults. Risk Management and Healthcare Policy. Volume 17. 1301–1313. 1 indexed citations

Pan, Xiaoyu, et al.. (2023). Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression. Molecular and Cellular Biochemistry. 479(5). 1133–1147. 28 indexed citations

Zhang, Xueqing, et al.. (2023). Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics. Diabetes Metabolic Syndrome and Obesity. Volume 16. 873–882. 7 indexed citations

Yue, Lin, et al.. (2023). Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis. Diabetes Metabolic Syndrome and Obesity. Volume 16. 1941–1952. 1 indexed citations

Pan, Xiaoyu, Lin Yang, Shuqi Wang, et al.. (2023). Semaglutide alleviates inflammation-Induced endothelial progenitor cells injury by inhibiting MiR-155 expression in macrophage exosomes. International Immunopharmacology. 119. 110196–110196. 19 indexed citations

Pan, Xiaoyu, et al.. (2023). Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study. BMC Endocrine Disorders. 23(1). 191–191. 4 indexed citations

Pan, Xiaoyu, et al.. (2023). Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations. Journal of Inflammation Research. Volume 16. 1853–1865. 16 indexed citations

Chen, Shuchun, et al.. (2023). Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice. Diabetes Metabolic Syndrome and Obesity. Volume 16. 2549–2560. 6 indexed citations

10.

Chen, Xiaoyi, Shuchun Chen, Zelin Li, et al.. (2023). Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice. Frontiers in Pharmacology. 14. 975830–975830. 18 indexed citations

11.

Chen, Shuchun, Xing Chen, Lin Yue, et al.. (2022). Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model. Frontiers in Endocrinology. 13. 1046130–1046130. 43 indexed citations

12.

Chen, Xing, Shuchun Chen, Xiaoyu Pan, et al.. (2022). Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice. Drug Design Development and Therapy. Volume 16. 3893–3913. 10 indexed citations

13.

Pan, Xiaoyu, Shuchun Chen, Xing Chen, et al.. (2022). Effect of high-fat diet and empagliflozin on cardiac proteins in mice. Nutrition & Metabolism. 19(1). 69–69. 9 indexed citations

14.

Chen, Xing, Shuchun Chen, Lin Yue, et al.. (2022). A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice. Biochemical and Biophysical Research Communications. 621. 122–129. 8 indexed citations

15.

Pan, Xiaoyu, Xing Chen, Lin Yue, et al.. (2022). Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis. Biochemical and Biophysical Research Communications. 618. 30–37. 14 indexed citations

16.

Pan, Xiaoyu, et al.. (2022). Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice. Journal of Inflammation Research. Volume 15. 6409–6425. 15 indexed citations

17.

Yue, Lin, et al.. (2022). Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3519–3531. 5 indexed citations

18.

Pan, Xiaoyu, Xing Chen, Lin Yue, et al.. (2022). Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice. Biochemical and Biophysical Research Communications. 622. 22–29. 6 indexed citations

19.

Chen, Shuchun, et al.. (2022). An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism. Drug Design Development and Therapy. Volume 16. 3723–3735. 58 indexed citations

20.

Yue, Lin, Shuchun Chen, Xiaoyu Pan, et al.. (2022). Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice. Frontiers in Endocrinology. 13. 995007–995007. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact